Search Bar & Filters
Found 6 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying the use of a chlorhexidine gluconate CHG-impregnated antimicrobial incise drape during primary hip or knee replacement surgeries. This clinical trial aims to evaluate the drapes performance and safety, focusing on contamination rates and operative characteristics during surgery. The study is prospective, single-arm, and conducted in the United States with adult participants aged 22 years and older. Participants will have the CHG-impregnated incise drape applied to the surgical site before the incision and it will remain in place for the entire surgery. The study focuses on patients undergoing unilateral primary hip or knee arthroplasty procedures. The device application and monitoring occur only during the surgical procedure. During surgery, samples will be taken from the operative site to assess possible bacterial contamination. Safety and intraoperative performance outcomes will be measured throughout the procedure. Participants must be able to provide informed consent and return for all visits. The study will be completed by October 2026, with the primary outcome being the presence of contamination at the surgical site during surgery.
Actively Recruiting
Researchers are conducting a precision study to compare bone mineral density BMD measurements obtained from two low-dose x-ray exams using EOSedge biplanar full-body or full-spine imaging. The study aims to determine the measurement precision between the BMD assessments from these two exams. This single-center, prospective study involves 30 subjects who are indicated for radiography to evaluate spinal or other orthopedic conditions. Participants will undergo two EOSedge imaging exams during the study. The first exam is performed as part of their standard care, while the second exam is performed immediately afterward with repositioning between scans. The imaging outputs will be used for post-study calculations of BMD. Demographic and diagnostic information will be collected through case report forms, and subjects will complete a questionnaire based on international guidelines prior to the BMD scan. During the study, participants will be involved from consent through completion of both imaging exams. Researchers will review the precision of BMD measurements specifically for the spine and hip regions. Safety considerations include monitoring for any factors that may affect image quality or participant positioning. The study duration for each participant involves the imaging procedures on the same day, and data collected will inform the precision of BMD assessment using EOSedge technology.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the real-world impact, including safety and test accuracy, of the Galleri4 multi-cancer early detection blood test in Medicare beneficiaries aged 50 years and older. This multi-center prospective cohort study aims to represent the Medicare population and compares usual care with and without the addition of the Galleri test. The study focuses on screening for cancer and assessing how the test affects cancer diagnosis and management over time. Participants are grouped into two arms one receiving the Galleri test alongside usual care, and a second group receiving usual care alone without the Galleri test. The Galleri test involves blood collection and multi-cancer early detection testing with results returned to participants. The study is non-randomized and runs parallel for both groups, observing outcomes over up to three years. During the study, participants are monitored for the incidence of late-stage stage IV cancers. Researchers also track safety by counting invasive procedures prompted by test results, adherence to recommended cancer screenings, and healthcare resources used for cancer diagnostics. The total study duration includes up to three years of follow-up to observe outcomes, with no masking or blinding involved.
Actively Recruiting
Researchers are evaluating the Integrity Implant System in adults with rotator cuff tears of the shoulder. This study aims to confirm the devices performance, safety, and clinical benefit when used to augment rotator cuff tears, with or without repair. The trial focuses on reducing rotator cuff re-tear rates and improving shoulder function through a prospective, multi-center, single-arm, non-randomized post-market clinical follow-up. Participants will receive the Integrity Implant System during rotator cuff tear surgery, which may involve mini-open or arthroscopic approaches. The study will follow patients for up to 24 months after surgery, assessing repair integrity with MRI at 12 months and monitoring other functional outcomes and safety throughout the study period. During the study, participants will complete questionnaires measuring shoulder function, pain, and quality of life at screening, 6 weeks, 6 months, 12 months, and 24 months post-surgery. MRI scans will evaluate tendon repair quality and tissue regeneration. Safety will be tracked by recording adverse events. Participants need to follow rehabilitation instructions and attend all follow-up visits to support comprehensive evaluation of the implants performance.
Actively Recruiting
Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.
Actively Recruiting
Researchers are evaluating the SMR Stemless Reverse device compared to the SMR Reverse Shoulder System for total primary shoulder joint replacement. This study focuses on patients with shoulder joint dysfunction who continue to experience significant symptoms despite non-operative management. The goal is to show that the SMR Stemless Reverse is not inferior to the established SMR Reverse Shoulder System in restoring shoulder function and reducing pain. Participants will be randomly assigned to receive either the investigational SMR Stemless Reverse device or the control SMR Reverse Shoulder System. These devices are intended to address issues like severe arthropathy and rotator cuff deficiencies in the shoulder. Enrollment is expected to take about 24 months, and the study involves multiple centers. During the 24-month study period, participants will undergo assessments of shoulder function using measures such as the Constant Murley Score, American Shoulder and Elbow Surgeons Shoulder Score, Simple Shoulder Test, and range of motion tests at several timepoints. Safety will be monitored through the absence of revisions, reoperations, implant loosening, and adverse events. Imaging with CT and x-rays will also be performed. The study aims to comprehensively evaluate both safety and efficacy outcomes over this period.